Hearing Loss Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You developed hearing loss as an adult, in both ears, and it is mild to moderate in severity (confirmed by a hearing test)
- You are 40 years of age or older
- You have not worn hearing aids for more than 3 months in total previously
- You are able to read and understand patient education materials provided in the study
- You are willing to be randomly assigned to one of four groups in the study
- You own a smartphone
Who may not be able to join:
- Your hearing loss is too severe to be helped by over-the-counter hearing aids
- You have a problem with your middle ear or a type of hearing loss caused by a physical blockage or structural issue in the ear
- Your hearing loss is significantly worse in one ear than the other
- You have been diagnosed with a neurological condition such as dementia or Parkinson's disease, or you score below a certain level on a memory and thinking assessment (confirm with trial site)
- You do not speak English, as the study tests and materials are only available in English
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Vinaya Manchaiah, AuD, MBA, PhD, University of Colorado, Denver
Phone: 303-724-8465
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Abbreviated Profile of Hearing Aid Benefit (APHAB)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.